Biochips-Europe Market Status and Trend Report 2013-2023
Report Summary
Biochips-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biochips industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Biochips 2013-2017, and development forecast 2018-2023
Main market players of Biochips in Europe, with company and product introduction, position in the Biochips market
Market status and development trend of Biochips by types and applications
Cost and profit status of Biochips, and marketing status
Market growth drivers and challenges
The report segments the Europe Biochips market as:
Europe Biochips Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Biochips Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DNA chips
Lab-on-a-chip
Protein chips
Europe Biochips Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Biotechnology
Genomics and proteomics
Drug screening and development
Molecular diagnostics
Microfluidic technologie
Microarray and biosensors
Europe Biochips Market: Players Segment Analysis (Company and Product introduction, Biochips Sales Volume, Revenue, Price and Gross Margin):
Affymetric Inc
Illumina Inc
GE Healthcare Ltd
Agilent Technologies Inc
Roche NimbleGen
Life Technologies Corporation
EMD Millipore
Bio-Rad Laboratories Inc
Abbott Laboratories
Fluidigm Corporation
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Biochips-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Biochips industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Biochips 2013-2017, and development forecast 2018-2023
Main market players of Biochips in Europe, with company and product introduction, position in the Biochips market
Market status and development trend of Biochips by types and applications
Cost and profit status of Biochips, and marketing status
Market growth drivers and challenges
The report segments the Europe Biochips market as:
Europe Biochips Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Biochips Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
DNA chips
Lab-on-a-chip
Protein chips
Europe Biochips Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Biotechnology
Genomics and proteomics
Drug screening and development
Molecular diagnostics
Microfluidic technologie
Microarray and biosensors
Europe Biochips Market: Players Segment Analysis (Company and Product introduction, Biochips Sales Volume, Revenue, Price and Gross Margin):
Affymetric Inc
Illumina Inc
GE Healthcare Ltd
Agilent Technologies Inc
Roche NimbleGen
Life Technologies Corporation
EMD Millipore
Bio-Rad Laboratories Inc
Abbott Laboratories
Fluidigm Corporation
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BIOCHIPS
1.1 Definition of Biochips in This Report
1.2 Commercial Types of Biochips
1.2.1 DNA chips
1.2.2 Lab-on-a-chip
1.2.3 Protein chips
1.3 Downstream Application of Biochips
1.3.1 Biotechnology
1.3.2 Genomics and proteomics
1.3.3 Drug screening and development
1.3.4 Molecular diagnostics
1.3.5 Microfluidic technologie
1.3.6 Microarray and biosensors
1.4 Development History of Biochips
1.5 Market Status and Trend of Biochips 2013-2023
1.5.1 Europe Biochips Market Status and Trend 2013-2023
1.5.2 Regional Biochips Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Biochips in Europe 2013-2017
2.2 Consumption Market of Biochips in Europe by Regions
2.2.1 Consumption Volume of Biochips in Europe by Regions
2.2.2 Revenue of Biochips in Europe by Regions
2.3 Market Analysis of Biochips in Europe by Regions
2.3.1 Market Analysis of Biochips in Germany 2013-2017
2.3.2 Market Analysis of Biochips in United Kingdom 2013-2017
2.3.3 Market Analysis of Biochips in France 2013-2017
2.3.4 Market Analysis of Biochips in Italy 2013-2017
2.3.5 Market Analysis of Biochips in Spain 2013-2017
2.3.6 Market Analysis of Biochips in Benelux 2013-2017
2.3.7 Market Analysis of Biochips in Russia 2013-2017
2.4 Market Development Forecast of Biochips in Europe 2018-2023
2.4.1 Market Development Forecast of Biochips in Europe 2018-2023
2.4.2 Market Development Forecast of Biochips by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Biochips in Europe by Types
3.1.2 Revenue of Biochips in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Biochips in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Biochips in Europe by Downstream Industry
4.2 Demand Volume of Biochips by Downstream Industry in Major Countries
4.2.1 Demand Volume of Biochips by Downstream Industry in Germany
4.2.2 Demand Volume of Biochips by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Biochips by Downstream Industry in France
4.2.4 Demand Volume of Biochips by Downstream Industry in Italy
4.2.5 Demand Volume of Biochips by Downstream Industry in Spain
4.2.6 Demand Volume of Biochips by Downstream Industry in Benelux
4.2.7 Demand Volume of Biochips by Downstream Industry in Russia
4.3 Market Forecast of Biochips in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIOCHIPS
5.1 Europe Economy Situation and Trend Overview
5.2 Biochips Downstream Industry Situation and Trend Overview
CHAPTER 6 BIOCHIPS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Biochips in Europe by Major Players
6.2 Revenue of Biochips in Europe by Major Players
6.3 Basic Information of Biochips by Major Players
6.3.1 Headquarters Location and Established Time of Biochips Major Players
6.3.2 Employees and Revenue Level of Biochips Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BIOCHIPS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Affymetric Inc
7.1.1 Company profile
7.1.2 Representative Biochips Product
7.1.3 Biochips Sales, Revenue, Price and Gross Margin of Affymetric Inc
7.2 Illumina Inc
7.2.1 Company profile
7.2.2 Representative Biochips Product
7.2.3 Biochips Sales, Revenue, Price and Gross Margin of Illumina Inc
7.3 GE Healthcare Ltd
7.3.1 Company profile
7.3.2 Representative Biochips Product
7.3.3 Biochips Sales, Revenue, Price and Gross Margin of GE Healthcare Ltd
7.4 Agilent Technologies Inc
7.4.1 Company profile
7.4.2 Representative Biochips Product
7.4.3 Biochips Sales, Revenue, Price and Gross Margin of Agilent Technologies Inc
7.5 Roche NimbleGen
7.5.1 Company profile
7.5.2 Representative Biochips Product
7.5.3 Biochips Sales, Revenue, Price and Gross Margin of Roche NimbleGen
7.6 Life Technologies Corporation
7.6.1 Company profile
7.6.2 Representative Biochips Product
7.6.3 Biochips Sales, Revenue, Price and Gross Margin of Life Technologies Corporation
7.7 EMD Millipore
7.7.1 Company profile
7.7.2 Representative Biochips Product
7.7.3 Biochips Sales, Revenue, Price and Gross Margin of EMD Millipore
7.8 Bio-Rad Laboratories Inc
7.8.1 Company profile
7.8.2 Representative Biochips Product
7.8.3 Biochips Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories Inc
7.9 Abbott Laboratories
7.9.1 Company profile
7.9.2 Representative Biochips Product
7.9.3 Biochips Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.10 Fluidigm Corporation
7.10.1 Company profile
7.10.2 Representative Biochips Product
7.10.3 Biochips Sales, Revenue, Price and Gross Margin of Fluidigm Corporation
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOCHIPS
8.1 Industry Chain of Biochips
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIOCHIPS
9.1 Cost Structure Analysis of Biochips
9.2 Raw Materials Cost Analysis of Biochips
9.3 Labor Cost Analysis of Biochips
9.4 Manufacturing Expenses Analysis of Biochips
CHAPTER 10 MARKETING STATUS ANALYSIS OF BIOCHIPS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Biochips in This Report
1.2 Commercial Types of Biochips
1.2.1 DNA chips
1.2.2 Lab-on-a-chip
1.2.3 Protein chips
1.3 Downstream Application of Biochips
1.3.1 Biotechnology
1.3.2 Genomics and proteomics
1.3.3 Drug screening and development
1.3.4 Molecular diagnostics
1.3.5 Microfluidic technologie
1.3.6 Microarray and biosensors
1.4 Development History of Biochips
1.5 Market Status and Trend of Biochips 2013-2023
1.5.1 Europe Biochips Market Status and Trend 2013-2023
1.5.2 Regional Biochips Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Biochips in Europe 2013-2017
2.2 Consumption Market of Biochips in Europe by Regions
2.2.1 Consumption Volume of Biochips in Europe by Regions
2.2.2 Revenue of Biochips in Europe by Regions
2.3 Market Analysis of Biochips in Europe by Regions
2.3.1 Market Analysis of Biochips in Germany 2013-2017
2.3.2 Market Analysis of Biochips in United Kingdom 2013-2017
2.3.3 Market Analysis of Biochips in France 2013-2017
2.3.4 Market Analysis of Biochips in Italy 2013-2017
2.3.5 Market Analysis of Biochips in Spain 2013-2017
2.3.6 Market Analysis of Biochips in Benelux 2013-2017
2.3.7 Market Analysis of Biochips in Russia 2013-2017
2.4 Market Development Forecast of Biochips in Europe 2018-2023
2.4.1 Market Development Forecast of Biochips in Europe 2018-2023
2.4.2 Market Development Forecast of Biochips by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Biochips in Europe by Types
3.1.2 Revenue of Biochips in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Biochips in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Biochips in Europe by Downstream Industry
4.2 Demand Volume of Biochips by Downstream Industry in Major Countries
4.2.1 Demand Volume of Biochips by Downstream Industry in Germany
4.2.2 Demand Volume of Biochips by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Biochips by Downstream Industry in France
4.2.4 Demand Volume of Biochips by Downstream Industry in Italy
4.2.5 Demand Volume of Biochips by Downstream Industry in Spain
4.2.6 Demand Volume of Biochips by Downstream Industry in Benelux
4.2.7 Demand Volume of Biochips by Downstream Industry in Russia
4.3 Market Forecast of Biochips in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BIOCHIPS
5.1 Europe Economy Situation and Trend Overview
5.2 Biochips Downstream Industry Situation and Trend Overview
CHAPTER 6 BIOCHIPS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Biochips in Europe by Major Players
6.2 Revenue of Biochips in Europe by Major Players
6.3 Basic Information of Biochips by Major Players
6.3.1 Headquarters Location and Established Time of Biochips Major Players
6.3.2 Employees and Revenue Level of Biochips Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BIOCHIPS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Affymetric Inc
7.1.1 Company profile
7.1.2 Representative Biochips Product
7.1.3 Biochips Sales, Revenue, Price and Gross Margin of Affymetric Inc
7.2 Illumina Inc
7.2.1 Company profile
7.2.2 Representative Biochips Product
7.2.3 Biochips Sales, Revenue, Price and Gross Margin of Illumina Inc
7.3 GE Healthcare Ltd
7.3.1 Company profile
7.3.2 Representative Biochips Product
7.3.3 Biochips Sales, Revenue, Price and Gross Margin of GE Healthcare Ltd
7.4 Agilent Technologies Inc
7.4.1 Company profile
7.4.2 Representative Biochips Product
7.4.3 Biochips Sales, Revenue, Price and Gross Margin of Agilent Technologies Inc
7.5 Roche NimbleGen
7.5.1 Company profile
7.5.2 Representative Biochips Product
7.5.3 Biochips Sales, Revenue, Price and Gross Margin of Roche NimbleGen
7.6 Life Technologies Corporation
7.6.1 Company profile
7.6.2 Representative Biochips Product
7.6.3 Biochips Sales, Revenue, Price and Gross Margin of Life Technologies Corporation
7.7 EMD Millipore
7.7.1 Company profile
7.7.2 Representative Biochips Product
7.7.3 Biochips Sales, Revenue, Price and Gross Margin of EMD Millipore
7.8 Bio-Rad Laboratories Inc
7.8.1 Company profile
7.8.2 Representative Biochips Product
7.8.3 Biochips Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories Inc
7.9 Abbott Laboratories
7.9.1 Company profile
7.9.2 Representative Biochips Product
7.9.3 Biochips Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.10 Fluidigm Corporation
7.10.1 Company profile
7.10.2 Representative Biochips Product
7.10.3 Biochips Sales, Revenue, Price and Gross Margin of Fluidigm Corporation
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BIOCHIPS
8.1 Industry Chain of Biochips
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BIOCHIPS
9.1 Cost Structure Analysis of Biochips
9.2 Raw Materials Cost Analysis of Biochips
9.3 Labor Cost Analysis of Biochips
9.4 Manufacturing Expenses Analysis of Biochips
CHAPTER 10 MARKETING STATUS ANALYSIS OF BIOCHIPS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
